Another barrier to social media use by pharma? The FDA expects drug advertisements to use the same level of language to convey both safety and efficacy information, according to a pair of...

In a Notice of Violation letter to Lilly (see here), FDA cited two videos supposedly submitted by patients who take ADCIRCA, Lilly's drug approved for the treatment of Pulmonary Arterial Hypertension (PAH).The...

As reported over at minyanville.com ("Sign of the Times? Cosmetic Surgery Is Back"):According to a survey done by MEDACorp, plastic surgery and cosmetic procedures were up during the fourth quarter of 2009...

On January 29th new documents appeared in the FDA's docket that has been devised to collect commentary after the November 12-13 Part 15 meeting on social media and the Internet and medical...

I had an interesting Twitter conversation last week about the quality of online health information. Late last year we recruited an online panel to review health information for 3 months and while...

There's an article out from a group in Australia on the long-standing problem of "frequent hitter" compounds. Everyone who's had to work with high-throughput screening data has had to think about this...

This week, Epocrates Inc., the developer of mobile applications used by more than 900,000 healthcare professionals worldwide, revealed a new study of more than 350 clinicians conducted in the wake of Apple's...

 All of Washington is braced for the onslaught of a snow storm that the weather service has termed "paralyzing" - obviously unaware of the fact that Congress is in a state...

A new tax on profits from some patents and other intangible assets parked in overseas tax havens by American companies. That was the land mine in President Obama's budget this week. The...

This is the final post of a four-part series. What Would Steve Jobs Do? What Would Google Do? What Would Jake and Rocket Do? These are champs. What would a 'new marketing' champ do in Pharma and...